EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Differential structure and immunomodulatory functions of lipophosphoglycan between Leishmania spp

Lisa U Teufel, Leo A B Joosten, Jéssica C Dos Santos

Immunology Letters · 2024

DOI: 10.1016/j.imlet.2024.106885 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunology Letters, 2024. Verfasst von Lisa U Teufel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Radboud Center of Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, The Netherlands. Electr…. Hauptthemen laut MEDLINE: Leishmania, Glycosphingolipids, Leishmaniasis, Immunomodulation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leishmaniasis is a collective term for several tropical, neglected diseases caused by protozoans of the species Leishmania, 20 of which causing disease in humans ranging from localised self-healing lesions to chronic manifestations which affect the skin or inner organs. Although millions of infections are accounted for annually, treatment options are scarce and limited to medication associated with heavy side-effects and increasing antibiotic resistance. Case studies point towards immunotherapy as effective alternative treatment relying on immunomodulatory properties of e.g., the Bacillus Calmette-Guérin vaccine. Leishmania parasites are also known to modulate the immune system, yet the underlying macromolecules and surface molecules remain widely under characterised. With this short review, we aim to provide a complete summary of the existing literature describing one of the most expressed surface molecule on Leishmania spp, lipophosphoglycan (LPG), which shows great variability between different lifecycle stages and different Leishmania spp. Complete characterisation of LPG may aid to improve treatment and aid the development of vaccination strategies, and open new avenues to exploit the immunomodulatory properties of LPG in unrelated conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeishmaniaGlycosphingolipidsLeishmaniasisImmunomodulationHumansAnimals

Stichwörter der Autor:innen

ImmunomodulationLeishmania spp.LeishmaniasisLipophosphoglycan

Substanzen

lipophosphonoglycanGlycosphingolipids

Autor:innen und Institutionen

  • Department of Internal Medicine and Radboud Center of Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: lisa.teufel@radboudumc.nl.
  • Department of Internal Medicine and Radboud Center of Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, The Netherlands.

Zitieren

APA

Teufel, L. U., Joosten, L. A. B., & Dos Santos, J. C. (2024). Differential structure and immunomodulatory functions of lipophosphoglycan between Leishmania spp. Immunology Letters. https://doi.org/10.1016/j.imlet.2024.106885

Vancouver

Teufel LU, Joosten LAB, Dos Santos JC. Differential structure and immunomodulatory functions of lipophosphoglycan between Leishmania spp. Immunology Letters. 2024. doi:10.1016/j.imlet.2024.106885

BibTeX
@article{Teufel2024,
  author = {Teufel, Lisa U and Joosten, Leo A B and Dos Santos, Jéssica C},
  title = {Differential structure and immunomodulatory functions of lipophosphoglycan between Leishmania spp},
  journal = {Immunology Letters},
  year = {2024},
  doi = {10.1016/j.imlet.2024.106885}
}
Kostenlos starten →